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Measurements for outcomes reporting are not fully formed and utilized in the American addiction industry, though
formulated and adopted elsewhere in the world. While studies have established demographic information about
those needing and receiving treatment as well as the facilities that offer such treatment, short- and long-term
outcomes are scantily reported. This commentary serves as a call to action to developing such metrics in the US
by illustrating the benefits to treatment providers and clients of creating outcomes standards, and the subsequent
improvements in quality of care needed to reach those standards. Benefits of developing these metrics beyond
improved quality of care may also include a more efficient allocation of resources, such as time and money. Additionally,
the delivery of more effective, personalized, and outcomes-driven addiction treatment may increase client buy-in and
foster a more open communication channel between clients and providers during and after treatment.
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Recent data from the Substance Abuse and Mental Health
Services Administration’s (SAMHSA’s) National Survey on
Drug Use and Health [1] (NSDUH) indicates that 23.5
million Americans aged 12 or older (approximately 9.4 %
of the American population over age 12) are current
illicit drug users. Of these illicit drug users, 11.2 %
receive treatment for substance use disorders and addic-
tion [1]. According to SAMHSA’s National Survey of
Substance Abuse Treatment Services [2] (N-SSATS),
14,311 addiction treatment facilities or centers in the
US provided care for 1.25 million clients in 2012. 54.9 %
of admitted cases, in one national survey, have had at
least one prior treatment episode [3]. While demo-
graphic data about those struggling with addiction are
readily reported [1, 3, 4], less information is available on
those who have completed or exited a treatment facility.
SAMHSA’s Treatment Episodes Data Set [3] (TEDS) re-
ports on number of prior treatment episodes upon entry
into a treatment center; however indicators of treatment
effectiveness and follow-up data are not explicitly and
regularly tracked on a national level. Furthermore,* Correspondence: ruchi@drugabuse.com
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publicly available further highlighting this lack of infor-
mation, as well as exposing a missed opportunity to
qualitatively evaluate individualized treatment plans.Main text
Standardized tools for addiction professionals to meas-
ure short- and long-term outcomes and success, across
multiple metrics, are not readily available in the US. In
fact, the definition of “success” as it pertains to recovery
is, at best, vaguely defined. For some, including 12-Step
adherents, “success” is complete abstinence from any
substance, whereas others may consider “success” to
include the use of pharmacotherapies to manage symp-
toms and cravings, or employing techniques to use a
particular substance responsibly [5]. Further still, the
concept of “recovery” is ill-defined, and is generally
poorly understood [6]. Peer reviewed studies on “suc-
cess” and outcomes lack universal consensus for the
American addiction treatment system [7], and are lim-
ited in their practical application. For example, the
prominent TEDS-D survey defines “success” solely as
completing a treatment program. While more compre-
hensive outcomes measures have been investigated on
facility [8] and state [9, 10] levels, long-term, multi-
metric measures on a national scale have seldom beenal. This is an Open Access article distributed under the terms of the Creative
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wise, from governing bodies. Analogous metrics have,
however, been created for addiction treatment systems
elsewhere. The European Union, with support from the
United Nations, has published extensive survey tools and
guidelines for addiction treatment providers to measure
and assess outcomes [11–13]. Similarly, the Australian
government provides metrics and compulsory standards,
as well as toolkits containing guidelines, resources, and
educational materials [14].
Relapse rate has long been the standard indicator by
which recovery success is measured within the industry.
Historically though, documentation of this metric has
been inconsistent, and has relied heavily on estimated
figures. Estimates suggest that as many as 80 % of those
who seek and complete addiction treatment will relapse
after treatment termination [15]. These grim statistics
suggest, perhaps, that relapse rate cannot serve as the
sole indicator of recovery success, lest the industry as a
whole be interpreted as widely ineffectual. Addiction
treatment and recovery are multifaceted processes, and
treatment success cannot be determined by a single
metric. While relapse rates may indicate some facet of
success, other metrics, such as comorbidities; personal,
legal, and emotional state; and external conditions, may
prove significant to long-term recovery success and
should be considered as potential metrics to determining
a composite success variable [16].
The currently available data on post-rehabilitation out-
comes is inconsistent, and demonstrates a lack of report-
ing in the addiction space, which can contribute to two
major consequences. First, without accurate outcomes
evaluation, facilities offering poor quality of care are able
to continue offering such treatment without regular
evaluation. This absence of measurements and tracking
also results in a poor allocation of resources: facilities
offering poor treatment quality continue to consume
resources that would otherwise be better spent by facilities
engaging in ethical, high quality treatment. Secondly,
without outcomes measurements, there are fewer options
for conducting quality improvement initiatives, both on
the facility level and on a broad level throughout the
space. This stagnates the industry, as there are no quan-
tifiable standards to achieve and surpass; rather, progress
becomes more ideological and thus, harder to define. To
motivate constant quality improvement, measurable out-
comes must be assessed and publicly reported.
Outcomes are directly dependent on the level of care
received throughout treatment. By setting outcomes
standards, the quality of treatment may elevate, and the
form of treatment delivery may change to meet these
standards. Dialogue on treatment methodologies is
widespread in the addiction space, often focused on
which particular treatment method is the most effective.Following the evidence borne from current trends in
the broader American healthcare system, this dialogue
should include personalized treatment plans [17, 18].
Designing and implementing outcomes reporting, based
on leading treatment methodologies, would, in effect,
install those methodologies into facilities’ practices.
An outcomes reporting system that incorporates
leading treatment methodologies could have profound
effects on the treatment space. Through delivering more
effective outcomes-driven treatment, with standards that
allow for individualization, clients may engage in build-
ing a treatment plan that is best suited to their needs,
preferences, and belief system [17]. This possibility may
increase buy-in from clients, who would otherwise be
resistant to receiving treatment without a more trust-
founded and personal connection to the treatment plan
and provider – ultimately culminating in increased treat-
ment adherence, setting the client up for long-term
success [17–20]. By involving clients in the development
of their own treatment plan, clients may feel more
empowered and profoundly engaged with the recovery
process. The clients become active participants, rather
than resigned recipients of a rote prescription for an im-
mutable treatment process.
The ways in which outcomes are measured may also
benefit post-treatment client buy-in. Previous clients,
who struggle or relapse after receiving treatment, may
be difficult to reach for follow-up. These past clients
may feel guilt, shame, or defeat, thus prompting them
to distance themselves from their previous treatment
facility [21]. A personal treatment plan may make the
client feel more connected to the treatment provider;
therefore, opening the communication channel between
alumni and treatment centers to follow-up or receive
additional help.
Increasing treatment effectiveness also requires asses-
sing aspects of treatment beyond what is considered
clinical. Administrative assessments must be conducted
to determine which services a treatment provider is
equipped to provide. Attention must be drawn to facil-
ities’ physical accommodations and the abilities of the
staff, including credentials, legal limitations, and staff-to-
client ratios. Accurate and truthful assessments of these
capabilities will allow for facilities to provide only the
treatment plans they can manage, rather than overex-
tending themselves and causing unnecessary expendi-
tures. Treatment providers must also consider who is an
ideal client for their center – one whose needs align best
with the providers’ missions, skills, and services. Ideal
matches allow for the right treatment to be delivered at
the right time with the right resources to the right
people. Doing so allows for a much more efficient allo-
cation of resources, which saves clients and treatment
providers time, money, and personnel.
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Ultimately, more effective treatment driven by smarter
decision-making and outcomes standards has the cap-
ability to benefit clients and their loved ones, as well as
facilities themselves. In addition to the time, money, and
other resources saved for both clients and facilities, facil-
ities have the added benefit of using outcomes measures
for accreditation, marketing materials, and their reputa-
tion in the space. A multimetric system for evaluating
outcomes must be developed to motivate enhanced
treatment effectiveness, cyclically benefiting individuals
and facilities in the long-term. Future projects should
identify these metrics using those established in the
European Union and Australia as guides, and develop a
standardized process by which outcomes can be mea-
sured and reported.
Abbreviations
SAMHSA: Substance abuse and mental health services administration;
NSDUH: National survey on drug use and health; N-SSATS: National survey of
substance abuse treatment services; TEDS: Treatment episodes data set.
Competing interests
The Coalition Against Drug Abuse is affiliated with Recovery Brands LLC.
Recovery Brands LLC has financially supported this paper.
Authors’ contributions
RMS and AC conducted literature reviews. RMS, AC, and AKM planned and
prepared this commentary. All listed authors have given final approval of this
document, and agree to be accountable for all aspects of the work.
Authors’ information
RMS holds a Master’s degree in Bioethics, with a concentration on health care
research ethics. Previous works conducted by RMS include physician-industry
transparency research at The Cleveland Clinic Department of Bioethics, and
conflict of interest reporting at the Edmond J. Safra Center for Ethics at Harvard
University, where she served as a Research Ethics Fellow. AKM holds a Master’s
degree in Political Science, with experience conducting health policy research
in an international context, including projects contracted by the United Nations
and USAID. AC is a student in the Psychology Department at Fordham
University, specializing in addiction treatment.
Acknowledgements
The authors wish to acknowledge Jeff Smith, Abhilash Patel, and Melanie
Haber for their support of this publication, as well as Dr. Scot Thomas for his
editorial contributions.
Author details
1The Coalition Against Drug Abuse, 900 Broadway #704, New York, NY 10003,
USA. 2Department of Psychology, Fordham University, 441 E. Fordham Road,
Dealy Hall 226, Bronx, NY 10458, USA.
Received: 5 March 2015 Accepted: 2 May 2015
References
1. Substance Abuse and Mental Health Services Administration. Results from
the 2009 National Survey on Drug Use and Health: Volume I. Summary of
National Findings. Office of Applied Studies, NSDUH Series H-38A, HHS
Publication No. SMA 10–4856 Findings. Rockville, MD: US Department of
Health and Human Services; 2010.
2. United States Department of Health and Human Services. Substance Abuse
and Mental Health Services Administration. Center for Behavioral Health
Statistics and Quality: National Survey of Substance Abuse Treatment
Services (N-SSATS): 2012. Data on Substance Abuse Treatment Facilities.
Rockville, Maryland: US Department of Health and Human Services; 2013.3. United States Department of Health and Human Services. Substance Abuse
and Mental Health Services Administration. Center for Behavioral Health
Statistics and Quality: Treatment Episode Data Set—Admissions (TEDS-A)
2012. Rockville, MD: US Department of Health and Human Services; 2014.
4. United States Department of Health and Human Services. Substance Abuse
and Mental Health Services Administration. Center for Behavioral Health
Statistics and Quality: Treatment Episode Data Set—Discharges (TEDS-D),
2011. Rockville, MD: US Department of Health and Human Services; 2014.
5. Cherkis J. Dying To Be Free. Washington DC: The Huffington Post; 2015.
6. Laudet AB. What does recovery mean to you? Lessons from the recovery
experience for research and practice. J Subst Abuse Treat. 2007;33(3):243–56.
7. Graham K. Guidelines for using standardized outcome measures following
addictions treatment. Evaluation & the Health Professions. 1994;17:43–59.
8. Outcomes of Alcohol/Other Drug Dependency Treatment. Butler Center for
Research: Research Update. Center City, MN: The Hazelden Betty Ford
Foundation; 2011. p. 2.
9. Falkowski CL. Chemical Dependency Provider Performance Measures. St.
Paul, MN: Minnesota Department of Health Services; 2013. p. 803.
10. Hedden S, Guard M, Arndt S. State of Iowa Outcomes Monitoring System:
Evaluation Trend Report. Iowa Department of Public Health Contract
#5881NA01. Iowa City, IA: The Iowa Consortium for Substance Abuse
Research and Evaluation; 2011.
11. Schippers G, Broekman T. Measurements in the Addictions for Triage and
Evaluation – MATE 2.1 Manual and Protocol. English Edition. Bureau Beta,
Nijmegen, The Netherlands: European Monitoring Centre for Drugs and
Drug Addiction; 2003.
12. Donmall M, Jones A, Lawrinson P, Long J, Millar T, Royuela Morales L, et al.
Guidance for the measurement of drug treatment demand. New York, NY:
Global Assessment Programme on Drug Abuse in collaboration with the
European Monitoring Centre for Drugs and Drug Addiction; 2006. p. 58.
13. DeLeon G. CMRS Scales for Substance Abuse Treatment. Center for
Therapeutic Community Research (CTCR). New York, NY: European
Monitoring Centre for Drugs and Drug Addictions; 1993.
14. Deady M. Summary Table of Assessment and Outcomes Measure Tools.
Network of Alcohol & Other Drugs Agencies (NADA) as part of the Drug
and Alcohol and Mental Health Information Management Project. 2009:14.
15. Marlatt GA, Gordon JR, editors. Relapse Prevention: Maintenance Strategies in
the Treatment of Addictive Behaviors. New York: Guilford Press; 2005. p. 416.
16. Teesson M, Clement N, Copeland J, Conroy A, Reid A. The Measurement of
Outcome in Alcohol and Other Drug Treatment: A Review of Available
Instruments. National Drug and Alcohol Research Centre (NDARC) Technical
Report No. 90. Australia: University of New South Wales; 2000.
17. Drake RE, Cimpean D, Torrey WC. Shared decision making in mental health:
prospects for personalized medicine. Dialogues in Clinical Neurosciences.
2009;11:455–63.
18. Sacristán JA. Patient-centered medicine and patient-oriented research:
improving health outcomes for individual patients. BMC Med Informat Decis
Making. 2013;13:6.
19. Di Paula A, Long R, Wiener DE. Are your patients satisfied? Market Health
Serv. 2002;22:28–32.
20. Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to
treatment: three decades of research. A comprehensive review. J Clin Pharm
Therapeut. 2001;26:331–42.
21. O’Connor LE, Berry JW, Inaba D, Weiss J, Morrison A. Shame, guilt, and
depression in men and women in recovery from addiction. J Subst Abuse
Treat. 1994;11:503–10.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
